RenovoRx
RNXT
31 hedge funds and large institutions have $8.58M invested in RenovoRx in 2026 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 11 increasing their positions, 4 reducing their positions, and 5 closing their positions.
175% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 4
26% more capital invested
Capital invested by funds: $6.83M → $8.58M (+$1.75M)
5.43% more ownership
Funds ownership: 17.94% → 23.37% (+5.4%)
6% less funds holding
Funds holding: 33 → 31 (-2)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BL
Bleichroeder LP
New York
|
+$1.03M |
| 2 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$844K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$174K |
| 4 |
HF
HRT Financial
New York
|
+$31.4K |
| 5 |
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
|
+$24K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$101K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$75.6K |
| 3 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$19K |
| 4 |
GSC
Ground Swell Capital
Folly Beach,
South Carolina
|
-$11.4K |
| 5 |
CAWM
Capital Advisors Wealth Management
Yakima,
Washington
|
-$8.4K |
RNXT Hedge Fund Activity: Q1 2026 in Review
31 of the 8,173 institutional investors tracked by Wall St. Rank reported a position in RenovoRx (RNXT) for Q1 2026, worth a combined $8.58M — up 26% from $6.83M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of RNXT and 4 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 11 added.
The largest buyer was Bleichroeder LP, adding an estimated $1.03M. The largest seller was Renaissance Technologies, cutting an estimated $101K.
- 31 institutional investors held RenovoRx (RNXT) as of Q1 2026, down from 33 in Q4 2025.
- Funds reported $8.58M of RenovoRx stock for Q1 2026, up 26% quarter-over-quarter.
- 4 funds opened new RenovoRx positions in Q1 2026 and 5 closed out, a net change of -1 holder.
- The largest RenovoRx buyer in Q1 2026 was Bleichroeder LP, an estimated $1.03M added.
- The largest RenovoRx seller in Q1 2026 was Renaissance Technologies, an estimated $101K sold.
Based on aggregated 13F filings for Q1 2026.